Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00346892Phase 2Completed
A Phase 2 trial of human rotavirus vaccine, live attenuated in rotavirus infection, sponsored by GSK. Started Nov 2001; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00346892.